tADMET-White-Paper One of the key challenges of drug development is to better predict drug responses in humans. This white paper offers insights on how such challenges are being overcome by a portfolio of pre-validated in vivo and in vitro tools.

These tools offer solutions along various stages of the drug development pipeline and help improve drug candidate selection, increase clinical success rates, and reduce costs. Applications include use in early in vitro screening, preclinical in vivo studies, and in clinical phases.

Download This White Paper To Learn More About:
  • Genetically humanized mouse models for studying drug metabolism, disposition, and toxicity.

  • Liver Humanized mice and their use in ADME and toxicity studies.

  • Human HepaCur™ hepatocytes and upcyte® hepatocytes and their use in in vitro studies.

  • Hepatocytes derived from genetically engineered (humanized and knockout) mouse models. 

  • FDA accepted mouse models for short-term carcinogenicity studies

Complete the Form to Download Your Copy »

Get Your Copy Now!

    
© 2019 Taconic Biosciences, Inc. All rights reserved.

© 2019 Taconic Biosciences, Inc. All rights reserved.

© 2014 Taconic Biosciences, Inc. All rights reserved.